Other Carcinomas and Undifferentiated Carcinoma, Pathology of the Ovary
Publisher
Springer International Publishing
Reference26 articles.
1. Abeln, E. C., Smit, V. T., Wessels, J. W., de Leeuw, W. J., Cornelisse, C. J., & Fleuren, G. J. (1997). Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumours. The Journal of Pathology, 183(4), 424–431. 2. Brown, E., Stewart, M., Rye, T., Al-Nafussi, A., Williams, A. R., Bradburn, M., Smyth, J., & Gabra, H. (2004). Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer, 100(10), 2148–2153. 3. Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., Hu, X., Ling, S., Soslow, R. A., Broaddus, R. R., Zuna, R. E., Robertson, G., Laird, P. W., Kucherlapati, R., Mills, G. B., Cancer Genome Atlas Research Network, Weinstein, J. N., Zhang, J., Akbani, R., & Levine, D. A. (2017). Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell, 31(3), 411–423. 4. Coatham, M., Li, X., Karnezis, A. N., Hoang, L. N., Tessier-Cloutier, B., Meng, B., Soslow, R. A., Blake Gilks, C., Huntsman, D. G., Stewart, C. J., Postovit, L. M., Köbel, M., & Lee, C. H. (2016). Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. Modern Pathology, 29(12), 1586–1593. 5. Fujii, H., Yoshida, M., Gong, Z. X., Matsumoto, T., Hamano, Y., Fukunaga, M., Hruban, R. H., Gabrielson, E., & Shirai, T. (2000). Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Research, 60(1), 114–120.
|
|